Spearheading a Paradigm Shift in Cell Therapy Manufacturing

Cell & Gene – January 25, 2021 – Cell therapies are revolutionizing modern medicine. Where traditional treatment methods have failed, cell therapies have beaten cancer into remission for the vast majority of patients with certain hematological malignancies. These types of results are unprecedented with any other class of medicines. After decades of research and development, the approval of the first two CAR-T cell therapies in 2017 marked the beginning of the commercialization phase in the field. With hundreds of trials in the clinic and the FDA projecting 10-20 approvals per year starting 2025[1], humanity is at the cusp of a new era in which powerful personalized medicines could eradicate many types of cancers that were once considered a death sentence.